Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report) was down 5.7% during mid-day trading on Tuesday . The company traded as low as $0.74 and last traded at $0.91. Approximately 657 shares changed hands during mid-day trading, a decline of 77% from the average daily volume of 2,799 shares. The stock had previously closed at $0.97.
Vaccinex Stock Performance
The business’s fifty day moving average is $0.60 and its 200-day moving average is $0.73. The firm has a market cap of $2.38 million, a P/E ratio of -0.02 and a beta of 1.10.
About Vaccinex
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Further Reading
- Five stocks we like better than Vaccinex
- Top Biotech Stocks: Exploring Innovation Opportunities
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Consumer Staples Stocks, Explained
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- Retail Stocks Investing, Explained
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
